
Sign up to save your podcasts
Or
There are several new strategies that have been emerging to treat patients with HER2+ breast cancer, and here to walk us through those that were highlighted at the 2020 ASCO Annual Meeting is Dr. Sara Tolaney, breast medical oncologist at the Dana-Farber Cancer Institute and Assistant Professor of Medicine at the Harvard Medical School.
4.4
1414 ratings
There are several new strategies that have been emerging to treat patients with HER2+ breast cancer, and here to walk us through those that were highlighted at the 2020 ASCO Annual Meeting is Dr. Sara Tolaney, breast medical oncologist at the Dana-Farber Cancer Institute and Assistant Professor of Medicine at the Harvard Medical School.
91,011 Listeners
60 Listeners
1 Listeners
3 Listeners
3 Listeners
0 Listeners
6 Listeners
18 Listeners
0 Listeners
707 Listeners
253 Listeners
3,336 Listeners
56,285 Listeners
433 Listeners
1,092 Listeners
6,070 Listeners
32 Listeners
40 Listeners
496 Listeners